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The serum level of IL-6 and expression of IL-6 mRNA in hepatocytes from regenerating liver were investigated in the rat. The IL-6 level in the 
serum was not significantly different from that of a control group of rats submitted to an acute experimental inflammation. IL-6 mRNA expression 
did not occur in the liver of hepatectomized rats as judged from Northern blotting experiments using an IL-6 riboprobe. These results suggest hat 
if IL-6 is implicated in hepatic regeneration, this cytokine is not produced by the regenerating liver and must be delivered exogenously to the liver 
to modulate hepatic regeneration. 
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1. INTRODUCTION 
Hepatic regeneration is a common phenomenon in 
mammals which leads to the restoration of the hepatic 
parenchyma [1,2] following agressions uch as carbon 
tetrachloride intoxication [3] or hepatectomy [4,5]. 
After two-third hepatectomy in rats, hepatocytes un- 
dergo mitosis within 24 to 36 hours and complete regen- 
eration is obtained within 2 or 3 weeks [I]. Several 
mediators are implicated in this response (for review, 
see [6]) including EGF and TGF a: [7-Q] which increase 
the mitotic activity, or TGF p [lO-121 which inhibits 
and stops it at the end of the regeneration. The interac- 
tions between these mediators during hepatic regenera- 
tion remain uncertain [6]. 
Interleukin-6 (IL-6) is a multifunctional cytokine 
which acts as a mediator of cell differentiation, of lym- 
phocyte function, and as a factor in the regulation of the 
hematopoietic system (for review, see [13]). IL-6 has 
been demonstrated to be the major mediator in the 
acute phase response [14], and it acts by a receptor 
which has been found on hepatocytes and hepatoma 
cells 115,161. Recently, it was suggested that IL-6 deliv- 
ered exogenously to the liver could induce a tissue re- 
generation [17]. This data led us to study IL-6 expres- 
sion in the regenerating liver in the rat. 
The aim of the present study was to determine the 
IL-6 serum concentration and the expression of its 
mRNA in the liver following hepatectomy in rats, in 
~orres~o~de~~e address: J.P. Lebreton, INSERM Unite 78, BP 73, 
F-76233 Bois-Guillaume Cedex, France. 
order to assess whether IL-6 could be produced by the 
liver following partial hepatectomy. 
2. MATERIALS AND METHODS 
2.1. Animals 
Adult male Sprague-Dawley, weighing 250-300 g, were purchased 
from Charles-River (St Aubin les Elbeuf, France). They were main- 
tained on a 12 h light, 12 h dark cycle with a standard laboratory chow 
and water available ad libitum. 
2.2. Surgical procedures 
Hepatectomies were performed under light ether anesthesia between 
09.00 h and 12.00 h. 30% hepatectomy consisted of resection of the 
median and left lateral obes of the liver. 80% hepatectomy consisted 
of resection of the median, left lateral, and right lateral lobes of the 
hver. Three control groups were realized simultaneously and consisted 
of laparotomy with mobilization of the liver and/or abscess by subcu- 
taneous injection of 4 ml/kg turpentine oil. 
Blood samples were collected from the tail tip at 0 h, 2 h, 6 h, day 
1, day 2, day 3, day 4, day 5, day 6, day 7. day 8, day 9, day 10, day 
11, day 14, day 17, day 22 and day 28. 
After sacrifice of the animals at 2 h, 4 h, 6 h, 12 h, 24 h, day 6, day 
10, day 14, day 28, the remaining fiver (segments VI and VII) was 
collected, immediately frozen in liquid nitrogen, and next stored at 
-80°C until used. 
2.3. Serum IL-6 determinatjon 
IL-6 in serum samples was assayed by a hybridoma growth stimula- 
tion assay using the mouse hybridoma 7TDl cell line obtained through 
the courtesy of Dr J. Van Snick (Ludwig Institute for Cancer Re- 
search, Brussels, Belgium). Cell numbers were evaluated colorimetri- 
tally after 4 days as previously described [I 81. A titre of 1 U/ml was 
assigned to material which produced half maximal growth of 7TDl 
cells. Samples were analyzed in duplicate, and the result expressed as 
the mean. The detection hmit of the assay was about 10 U/ml. Statis- 
tical analysis was performed by Mann-Whitney test, P values < 0.05 
were considered statistically significant. 
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2.4. Preparation of peritoneal activated macrophages 3. RESULTS AND DISCUSSION 
Rat peritoneal macrophages were obtained after 2 successive 
washes of the peritoneal cavity with 10 ml of MEM containing 10% 
bovine fetal serum and 1% glutamine. The cell suspension was filtered 
through sterile gauze and centrifuged at 150 x g for 4 min. Two sets 
of experiments were carried out. The cell number was adjusted to I S-2 
x 10’ cellslmi culture medium. Ceils were plated in 75 cm’ flasks and 
LPS (10 gg/ml) was added for 4 h in the first set, and for 24 h in the 
second set. Cell cultures were incubated in a humid atmosphere at 
37°C in 5% CO, 95% air. 
2.5. Cellular RNA preparation 
Adherent rat peritoneal macrophages in the tissue culture disk were 
lysed directly with a guanidinium solution and RNA isolation was 
obtained by a single extraction with an acid guanidinium thiocyanate- 
phenolchloroform mixture as described [19]. Rat livers were homog- 
enized and total RNAs were obtained using the same one-step method. 
RNA concentrations were determined by measuring the absorbance 
at 260 nm. The integrity of RNA preparations was controlled by 
agarose electrophoresis and visualization of the 185 and 28s ribo- 
somal RNA bands after ethidium bromide staining. 
At 0 h serum IL-6 was below the level of detection in 
our assay but it rose within 2 h and reached a maximum 
at 4-6 h in the controls and in the two groups of hepat- 
ectomy (30% and 80%). Thereafter, the serum IL-6 level 
declined and was barely detectable at 72 h in all the 
groups. The maximal IL-6 level obtained 6 h after 
hepatectomy was not significantly different (P values 
between 0.1 and 0.45, Mann-Whitney test) from the 
maximum value obtained in controls (Figs. 1 and 2). 
Furthermore, the serum IL-6 levels were not different 
in the two groups of rats following 30% or 80% hepatec- 
tomy, although the importance of hepatic resection has 
been proved to modify hepatic regeneration [4]. 
2.6. Northern blot hvbridization 
Samples of total RNAs (2.5 pg) were denatured for 15 min at 55°C 
in 1 x MOPS buffer pH 7.0, formaldehyde 2.2 M, 50% deionized 
formamide and then loaded in a 1.2% agarose gel in 1 x MOPS buffer, 
formaldehyde 2.2 M and separated by electrophoresis at 25-50 V for 
14-20 h. Transfer of RNAs onto Hybond N+ nylon membranes 
(Amersham) was for 3 h in 50 mM NaOH. A RNA probe derived from 
a mouse IL-6 cDNA insert carried in a pGEM 4 vector (a generous 
gift from Dr. J. Doly. UPR 37, Viflejuif, France) was used. The RNA 
probe was synthesized in vitro using T7 RNA pofymerase, 1 ,ug of 
linearized plasmid DNA and 80 pCi [a-‘*P]UTP (3000 Ci/mmol, 
Amersham). For hybridization 1.7 x lo6 cpm/ml riboprobe was used. 
The blots were hybridized at 6O’C for 20 h. The filters were washed 
in 100 ml 1 x SSC containing 0.1% SDS for 20 min at 65°C and then 
five times in 500 ml 0.1 x SSC containing 0.1% SDS for 20 min at 65°C. 
The filters were exposed to a Hy~~lm-MP (Amersham) at -80°C 
with an intensifying screen for 3 days. 
Fig. 3 shows the lack of IL-6 mRNA in the livers of 
rats after 30% (lanes l-5) or 80% (lanes S-12) hepatec- 
tomy. For comparison, lanes 6 and 7 indicate the pres- 
ence of the two IL-6 mRNA species of 1.3 kb and 2.4 
kb [20] in RNA from rat peritoneal macrophages tim- 
ulated for 4 h (lane 6) and for 24 h (lane 7) with LPS. 
These data establish that foliowing hepatectomy in 
rats, IL-6 is released into the blood although the liver 
does not produce IL-6. In a previous study [21], we 
measured the production of IL-6 in rats suffering from 
an acute biliary sepsis and we showed that the IL-6 level 
was higher in the caval vein than in the suprahepatic 
veins. These previous results already suggested that 
liver is probably not involved in the synthesis of IL-6 
during inflammation. 
In the present work, it is noteworthy that serum IL-6 
levels in hepate~tomized rats and in the control groups 
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Fig. I. Effect of subcutaneous injection of turpentine (o), laparotomy (D), turpentine and laparotomy (D), on the blood level of IL-6 in three different 
groups of rats (3 to 5 rats in each group). Blood samples were collected from the tail tip and serum IL-6 was measured in duplicate at three different 
diIutions using the 7TDI hybridoma growth stimulation assay. Results are average values from 3 to 5 rats per time in each group. 
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Fig. 2. Kinetics of production of IL-6 in the serum of rats following 30% (H), or 80% (0) hepatectomy. Blood samples and determination of IL-6 
were obtained as Indicated in Fig. 1. 
are similar. Maximum IL-6 levels are higher in rats after 
hepatectomy although the difference is not statistically 
significant. In human, Cruickshank et al. [22] have 
shown that the serum IL-6 level after surgery is corre- 
lated with the duration and severity of the surgical pro- 
cedure. The increase of serum IL-6 observed in our 
present study probably resulted from the surgical stress 
which was higher in the groups of hepatectomized rats. 
This suggests that the liver is not implicated in IL-6 
synthesis during hepatic regeneration. The absence of 
expression of IL-6 mRNA in the regenerating liver is in 
keeping with this conclusion. Contradictory data have 
been published about IL-6 mRNA production in the 
liver. Tovey et al. [23] have shown that IL-6 mRNA was 
detected in the liver of normal individuals. These au- 
thors considered that IL-6 could be an autocrine regula- 
tor of hepatocyte growth. It has been reported that IL-6 
secreted by certain rat hepatoma cell lines exerted an 
autocrine effect in vitro and induced the transcription 
of endogenous acute phase genes [24]. In contrast and 
despite the use of a sensitive IL-6 riboprobe or using the 
polymerase chain reaction, Gauldie et al. [25] and 
Northernann et al. [26] did not find any IL-6 mRNA 
expression in normal liver, nor in the liver of rats under- 
going an acute-phase response following turpentine in- 
jection, suggesting that Kupffer cells were not especially 
activated during acute-phase response. However these 
authors did observe IL-6 mRNA expression in cultures 
of hepatocytes in absence of corticosteroid, which con- 
stitutes non physiologic conditions. 
Although the liver does not produce IL-6 during he- 
patic regeneration, our study has shown an elevated 
level of IL-6 in rat serums following hepatectomy. As 
Koga et al. [17] have observed that a treatment of rats 
by IL-6 could induce a proliferative response in hepato- 
cytes, it seems then reasonable to consider that an in- 
creased IL-6 production may interfere with hepatocyte 
proliferation. A delivery of IL-6 of exogenous origin 
would enhance hepatocyte mitosis. Another cytokine, 
the leukemia inhibitory factor (LIF) close to IL-6 in its 
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Fig. 3. Detection of IL-6 mRNA by Northern hybridization. Twenty-five pg total RNA were isolated from rat liver at various times after 30% 
hepatectomy (tracks l-5) and after 80% hepatectomy (tracks 8-12). Twenty-five mg total RNA were isolated from rat peritoneal macrophages 
that were stimulated 4 h (track 6) or 24 h (track 7) previously with 10 mg/ml LPS. The 2 rat IL-6 mRNA species of 1.3 kb and 2.4 kb are indicated. 
Northern gel analysis was probed with “P-labeled RNA antisense from mouse IL-6 cDNA as described in section 2. The cross-hybridization of 
the riboprobe with 18s ribosomal RNAs indicate homogeneity in total RNA loading. 
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function has been shown to be induced in regenerating 
liver (G. Baffet et al., submitted). Further studies are 
necessary to pinpoint the interactions between IL-6 and 
other growth factors, and the possible inhibiting or acti- 
vating action of IL-6 during hepatic regeneration. 
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